Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies.

Gandelman JS, Byrne MT, Mistry AM, Polikowsky HG, Diggins KE, Chen H, Lee SJ, Arora M, Cutler C, Flowers M, Pidala J, Irish JM, Jagasia MH.

Haematologica. 2018 Sep 20. pii: haematol.2018.193441. doi: 10.3324/haematol.2018.193441. [Epub ahead of print]

2.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.

Gatwood KS, Culos KA, Binari LA, Engelhardt BG, Kassim A, Byrne MT, Goodman SA, Chinratanalab W, Sengsayadeth SM, Greer JP, Jagasia M, Savani BN.

Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14. No abstract available.

PMID:
29540851
3.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

Johnpulle RA, Paczesny S, Jung DK, Daguindau E, Jagasia MH, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Byrne MT, Engelhardt BG.

Biol Blood Marrow Transplant. 2017 Mar;23(3):529-532. doi: 10.1016/j.bbmt.2016.12.627. Epub 2016 Dec 21.

4.

Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Galvin P, Thompson D, Ryan KB, McCarthy A, Moore AC, Burke CS, Dyson M, Maccraith BD, Gun'ko YK, Byrne MT, Volkov Y, Keely C, Keehan E, Howe M, Duffy C, MacLoughlin R.

Cell Mol Life Sci. 2012 Feb;69(3):389-404. doi: 10.1007/s00018-011-0856-6. Epub 2011 Oct 21. Review.

PMID:
22015612
5.

What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge.

Kim R, Byrne MT, Tan A, Aucejo F.

Oncology (Williston Park). 2011 Mar;25(3):283-91, 295. Review.

6.

Recent advances in research on carbon nanotube-polymer composites.

Byrne MT, Gun'ko YK.

Adv Mater. 2010 Apr 18;22(15):1672-88. doi: 10.1002/adma.200901545.

PMID:
20496401
7.

Postsplenectomy thromboembolic disease in congenital sideroblastic anaemia.

Byrne MT, Bergman AK, Ruiz AI, Silver BJ, Maciejewski JP, Tiu RV.

BMJ Case Rep. 2010 Sep 17;2010. pii: bcr1220092514. doi: 10.1136/bcr.12.2009.2514.

8.

Preparation of buckypaper-copper composites and investigation of their conductivity and mechanical properties.

Byrne MT, Hernandez YR, Conaty T, Blighe FM, Coleman JN, Gun'ko YK.

Chemphyschem. 2009 Mar 23;10(5):774-7. doi: 10.1002/cphc.200800750.

PMID:
19226497
9.

Fiber technology for reliable repair of skeletal muscle.

Franklin JE, Marler JJ, Byrne MT, Melvin AJ, Clarson SJ, Melvin DB.

J Biomed Mater Res B Appl Biomater. 2009 Jul;90(1):259-66. doi: 10.1002/jbm.b.31280.

PMID:
19085943
10.

Chemical functionalization of carbon nanotubes for the mechanical reinforcement of polystyrene composites.

Byrne MT, McNamee WP, Gun'ko YK.

Nanotechnology. 2008 Oct 15;19(41):415707. doi: 10.1088/0957-4484/19/41/415707. Epub 2008 Sep 4.

PMID:
21832658
11.

Improved mechanism for capturing muscle power for circulatory support.

Trumble DR, Melvin DB, Byrne MT, Magovern JA.

Artif Organs. 2005 Sep;29(9):691-700. Review.

12.

A durable load bearing muscle to prosthetic coupling.

Melvin DB, Klosterman B, Gramza BR, Byrne MT, Weisbrode SL, Litsky AS, Clarson SJ.

ASAIO J. 2003 May-Jun;49(3):314-9.

PMID:
12790383
13.

Dental infection in vascular surgical patients.

Stansby G, Byrne MT, Hamilton G.

Br J Surg. 1994 Aug;81(8):1119-20.

PMID:
7953335

Supplemental Content

Loading ...
Support Center